A Positive Fecal Occult Blood Test: What Does It Mean, and What Should Happen Next?

In this article
FROM SCREENING TO DIAGNOSIS • UPDATED: 8 SEPTEMBER 2026
A positive result is a finding that needs assessment, not a diagnosis.
Most people with a positive fecal occult blood test do not have cancer. The next step must nevertheless be completed to identify the source of bleeding and remove any precancerous polyps. For most people, that step is colonoscopy.
Seeing "fecal occult blood: positive" on a laboratory report can be worrying. It is understandable to think immediately of cancer, but this test does not look for cancer cells. It looks for blood in stool that may be invisible to the eye. Cancer is one possible cause; polyps and benign sources of bleeding can produce the same result.
Both extremes are therefore wrong: treating the result as a definite cancer diagnosis or dismissing it because "I have hemorrhoids, so that must be why." The clinical benefit of testing emerges when the necessary assessment after a positive result is completed . For the background, see our article on what you need to know about colon and rectal cancer . [1, 9]
What Exactly Does a Fecal Occult Blood Test Show?
"Fecal" refers to stool, and "occult blood" means blood that may not be visible. FOBT is a general term for a group of tests. A positive result means that a blood signal above the method's threshold was detected in stool. It does not, by itself, identify where bleeding occurs, its cause, whether cancer is present or, if present, its stage.
The test type matters when interpreting the result. Your report may say FIT, an immunochemical method or guaiac/gFOBT . These investigate the same biological signal using different methods, with different sampling rules. [1, 2]
How Does FIT Differ from a Guaiac Test?
| Feature | FIT: Immunochemical Test | gFOBT: Guaiac Test |
|---|---|---|
| How does it work? | Uses antibodies specific to the globin component of human hemoglobin. | Uses a color reaction based on heme's chemical, peroxidase-like activity. |
| Source of bleeding | More oriented toward colorectal bleeding because globin breaks down in the upper digestive tract; it does not definitively locate the source. | Can be affected by bleeding in the upper or lower digestive tract. |
| Dietary effects | Dietary restrictions are generally unnecessary. Red meat itself does not make a human-hemoglobin-specific test positive. | Red meat and certain plant peroxidases may cause false positives; high vitamin C intake may cause false negatives. |
| Number of samples | Many kits use one stool sample; follow the product instructions. | Most screening protocols require samples from separate bowel movements. |
| After a positive result | Colonoscopy is the standard follow-up assessment. | Colonoscopy is the standard follow-up assessment. |
Diet or medicine instructions for guaiac testing should not automatically be applied to FIT. Prescribed medicines should not be stopped for either test without discussing this with a doctor. Keeping the test brand, method and laboratory notes helps with follow-up assessment. [2, 3]
Does the Number or "+" Sign Indicate Cancer Severity?
Quantitative FIT may be reported, for example, in µg hemoglobin/g stool . Higher fecal hemoglobin is associated with a greater likelihood of significant bowel disease in some patient groups, but it is not a diagnosis or stage by itself. Kits, units and positivity thresholds differ. ng/mL and µg/g values should not be compared directly without knowing the kit's sampling and buffer characteristics.
For example, some pathways for symptomatic patients in England use a referral threshold of 10 µg/g. It would be wrong to apply this to every screening kit in Türkiye. A result considered positive by the laboratory should not be dismissed because "the number is low." [5, 20]
What Can Cause a Positive Result?
| Possible Cause | How Should It Be Interpreted? |
|---|---|
| Polyps such as adenomas or serrated lesions | Some are precancerous. Finding and removing them is valuable even when no cancer is present. |
| Colon or rectal cancer | May release microscopic blood into stool. Definitive diagnosis requires appropriate tissue examination. |
| Hemorrhoids or anal fissure | Can bleed, but their presence does not prove there is no other bowel lesion. |
| Diverticular disease or angiodysplasia | Pouches in the bowel wall or vascular lesions may bleed. |
| Inflammatory or infectious bowel disease | Bleeding may accompany diarrhea, abdominal pain or other findings. |
| Sampling problems or contamination with blood from elsewhere | Menstrual blood, blood from the urinary tract or improper sampling may affect assessment and should be reported to the doctor and laboratory. |
"False positive for cancer" does not necessarily mean "the test measured blood incorrectly." The test may have detected real bleeding from a noncancerous cause. Polyps or cancer can coexist with hemorrhoids. Irritable bowel syndrome alone does not explain bleeding. [1, 3]
What Is the Chance of Cancer? Reading the Numbers Correctly
There is no single rate that applies to everyone. Age, family history, symptoms, test threshold and screening program affect the probability. It is misleading to present a small hospital series as "the risk for everyone with a positive FOBT."
Mohan and colleagues' 2022 meta-analysis: 34 studies in asymptomatic, average-risk screening populations. Values are pooled detection rates at colonoscopy after a positive FIT. Advanced adenomas are included within the any-adenoma group; these rates cannot be added and are not slices of a pie chart. They cannot be used to calculate personal risk. [4]
These data convey two messages together: a positive FIT usually does not mean cancer, but the likelihood of finding clinically important polyps is substantial. An "advanced adenoma" is not a cancer diagnosis: it is a precancerous lesion with higher risk because of size or microscopic features. We describe polyp types in detail in colon polyps and their treatment . [4]
Can I Skip Colonoscopy If a Repeat Test Is Negative?
Generally, no. Polyps and tumors may bleed intermittently. A negative sample taken on another day does not cancel an earlier positive result. After a valid positive screening test, the next step is to investigate the cause with colonoscopy, rather than "confirming" it with another stool test.
A laboratory result described as "invalid sample," "insufficient material" or "unable to process" is different and may require a new sample. A positive result and a technically invalid result should not be placed in the same category. [5, 19]
Can a Blood Test, Stool DNA Test or PET/CT Replace It?
A negative result from another screening test after a positive FIT does not remove the need for colonoscopy. Blood and stool DNA tests look for different biological signals and do not provide the same information about small lesions or polyps. Routine abdominal CT and PET/CT also cannot replace colonoscopy's assessment of the colonic lining.
We discuss new blood-based screening technologies in fragmentomics- and methylation-based colon cancer screening . Their appropriate role is to improve screening access for suitable people, not to cancel diagnostic assessment after a positive stool test. [2, 12]
How Soon Should Colonoscopy Be Performed?
Start arranging an appointment when you receive the result and plan colonoscopy at the earliest suitable opportunity . For a generally well person without other symptoms, a positive result alone does not mean "an emergency colonoscopy tonight." However, waiting for months without oversight or until the next screening round is inappropriate.
In Forbes and colleagues' systematic review, delays beyond nine months after a positive FIT were associated with more colorectal cancers and diagnosis at a more advanced stage. These studies were observational and do not establish one definite, safe waiting limit. Do not conclude, "I can wait up to nine months." Symptoms, anemia and personal risk may require faster assessment. [7]
Why Does Completing Follow-Up Matter?
Italian observational cohort: 111,423 FIT-positive people; 88,013 underwent program colonoscopy and 23,410 did not. Ten-year cumulative colorectal cancer mortality is shown. The unadjusted absolute difference was 9.2 deaths per 1,000 people; adjusted analysis found approximately twice the hazard of death. This was not randomized; the whole difference cannot be attributed solely to colonoscopy's causal effect. [8]
Screening means more than handing out kits: people with positive results need access to assessment and must not be lost to follow-up. We also discuss previous research on colonoscopy's preventive role in colonoscopy and colorectal cancer mortality . [9]
Which Symptoms Require Faster Action?
Other findings requiring expedited medical assessment include unexplained iron-deficiency anemia, unintentional weight loss, a new persistent change in bowel habits, recurrent visible bleeding or a suspected mass on examination. These may have causes other than cancer; the aim is timely identification. Symptoms, stages and treatment of colon and rectal cancer discusses these distinctions more fully. [10, 13]
Screening Age and Investigating a Positive Result Are Different Issues
Screening is for people without symptoms. Investigating a positive test or alarm finding is diagnostic assessment. Being below screening age therefore does not prevent investigation of a positive result.
| Context | Starting Age and Frequency | Implications for a Positive Result |
|---|---|---|
| Türkiye's national program | FOBT every two years for women and men aged 50–70; colonoscopy every 10 years within the program. | Family health centers and KETEM/relevant screening units are access points. Positive results should not wait for the routine two-year repeat. |
| US USPSTF: average risk | Screening at ages 45–75; individual decisions at 76–85. Repeat annually if FIT is selected. | These ages and intervals differ from Türkiye's national program. Positive stool tests are assessed with colonoscopy. |
| Family History, Hereditary Syndrome or Particular Risk | Starting age and method are individualized; earlier, direct colonoscopy may be needed. | The standard age table should not automatically be applied to high-risk people. |
We explain why the US starting age was lowered to 45 in changes to colorectal cancer screening age . You do not need to reach a particular age before investigating an existing positive result. At a very advanced age or with serious comorbidities, benefits, safety and personal preferences are considered together. [11, 12]
How Should You Prepare for Colonoscopy?
Colonoscopy uses a flexible camera to assess the inner surface of the large bowel. Suitable polyps can be removed during the same procedure, and suspicious lesions biopsied. A biopsy does not always mean suspected cancer; samples may also assess inflammation. For details, read why and how colonoscopy is performed . [13]
Bowel Preparation Is Part of Diagnosis
Remaining stool may hide polyps and mucosa. Current recommendations support split-dose bowel preparation for suitable patients: part of the cleanser is taken the day before and the rest on the procedure day. Follow your center's plan for the product, fluid volume, diet and fasting times. People with kidney or heart disease should not use someone else's preparation prescription.
Tell the procedure unit if you cannot finish preparation, are vomiting or find instructions unclear. An examination with inadequate preparation cannot provide the reassurance of a "clear colonoscopy." After inadequate preparation, an examination of sufficient quality should be completed as soon as possible, particularly after a positive screening test. [14]
| Information to Share | Why It Matters |
|---|---|
| Aspirin, clopidogrel and anticoagulants | Bleeding risk from polyp removal is weighed against clotting risk from stopping medication. There is no single stopping schedule for every medicine. |
| Insulin and other diabetes medicines | Medication and glucose monitoring are planned for fasting and bowel preparation. |
| Iron preparations and all supplements | Some products may affect preparation or visibility; the center may give specific instructions. |
| Kidney/heart disease, sleep apnea or previous anesthesia problems | May change cleanser selection, fluid planning or sedation assessment. |
| Previous colonoscopy and pathology reports | Help determine the need, priority and follow-up plan for a new examination. |
If sedation is planned, arrange an escort and transport home in advance, and follow instructions about driving afterward. Colonoscopy is safe for most people but carries risks, including bleeding, perforation and sedation-related problems. Risk varies with age, medical conditions and interventions performed, and should be discussed alongside the expected benefit of investigating the positive test. [13, 17]
What Makes a Colonoscopy High Quality?
It is not enough simply to have the procedure; adequate preparation and examination of the entire bowel are equally important. The report should state preparation quality, whether the cecum was reached, lesion locations and sizes, removal status and the pathology plan.
Endoscopy quality indicators include adenoma detection rate (ADR) and sessile serrated lesion detection rate . Not every polyp is an adenoma, so overall polyp detection rate and ADR are different measures. FIT-positive people also have a higher polyp likelihood than people undergoing primary screening colonoscopy. Rates from different patient populations should not be compared as equivalent.
The 2024 ASGE/ACG update excludes examinations after positive stool tests from general ADR calculations. Useful patient questions include: "Was my preparation adequate?" "Was the entire bowel examined?" "Were all polyps completely removed?" and "When will I need follow-up after pathology?" [15]
What Happens After Colonoscopy?
Clinical assessment and colonoscopy with appropriate preparation
Do not accept the result as sufficient; plan an early repeat or complementary method to complete assessment.
Without symptoms or anemia, follow personal risk/screening program recommendations; investigate further if findings persist.
Remove/treat as needed; determine follow-up from pathology, number, size and procedure quality.
Tissue assessment, staging and a multidisciplinary treatment plan.
This diagram shows the general approach. Serious comorbidities or inability to perform the procedure require individualized planning.
Does Finding a Polyp Immediately Mean Cancer?
No. Pathology determines polyp type, dysplasia grade and whether cancer is present. Follow-up intervals depend on colonoscopy quality and lesion characteristics , not the original positive FOBT. The examples below come from the US Multi-Society Task Force and apply to average-risk people with high-quality examinations and complete removal of all polyps. [16]
| Colonoscopy / Pathology Finding | Example Follow-Up Interval |
|---|---|
| Normal, high-quality colonoscopy | US guidance recommends 10 years at average risk; rules for returning to organized FIT programs vary by country. |
| 1–2 tubular adenomas, each smaller than 10 mm | 7–10 years |
| 3–4 tubular adenomas, each smaller than 10 mm | 3–5 years |
| Adenoma at least 10 mm, high-grade dysplasia or villous features | Usually 3 years |
| Adenoma / sessile serrated lesion at least 20 mm removed piecemeal | Early follow-up at approximately 6 months |
Serrated lesions, numerous polyps, hereditary syndromes, family history, cancer-containing polyps or incomplete removal require separate assessment. A personal follow-up date cannot be set without reviewing both the procedure and pathology reports. [16]
Is Gastroscopy Needed If Colonoscopy Is Normal?
In an asymptomatic person without iron-deficiency anemia, a normal, high-quality colonoscopy after a positive FIT generally does not warrant gastroscopy solely because FIT was positive. Iron-deficiency anemia, black stool, upper gastrointestinal symptoms or ongoing bleeding change the approach. Differences between guaiac testing and FIT in sensitivity to upper gastrointestinal bleeding are also considered. [18, 3]
Frequently Asked Questions and Common Mistakes
Could Aspirin, NSAIDs or Blood Thinners Have Caused the Positive Result?
These medicines may affect bleeding tendency, and some cause real gastrointestinal bleeding. It is nevertheless wrong to cancel assessment by attributing the result only to medication. Routine discontinuation before FIT screening is not recommended. Medication use before the test and medication planning before colonoscopic polyp removal are separate issues. The relevant doctor should decide whether prescribed medicines are stopped. [6]
I Have No Symptoms. Does It Still Matter?
Yes. Screening aims to find important lesions before symptoms appear. The absence of pain, weight loss or visible bleeding does not remove the need to investigate a positive screening result. [9]
I Recently Had Colonoscopy. Can I Ignore the Result?
No. Routine stool testing before the recommended follow-up interval is generally unnecessary. If a test was performed and is positive, however, the date and quality of the previous examination, completeness and polyp removal should be reviewed; repeat colonoscopy is generally considered. An earlier normal result does not automatically make a new positive result insignificant. [19]
What If Colonoscopy Cannot Be Performed?
If the procedure cannot be completed, there is a serious medical barrier or the patient declines it, a specialist may consider options such as CT colonography. This differs from routine abdominal CT and cannot biopsy or remove polyps. Abnormal findings may still require endoscopy. Decisions should follow discussion of the alternative's limitations. [17]
Does a Negative FIT Definitely Rule Out Cancer?
No. Bleeding may be intermittent, or a lesion may not bleed enough. Asymptomatic people should follow their screening program's repeat interval. Iron deficiency, persistent bowel changes, weight loss or bleeding require further consideration despite a negative result. NICE also emphasizes that low/negative FIT should not delay referral when clinical suspicion is strong. [10, 20]
What Should You Bring to Your Appointment?
- The FOBT/FIT report: date, method, numerical value if available, units and reference threshold.
- Previous colonoscopy and pathology reports.
- An up-to-date list of all medicines and supplements.
- A brief note about the duration of bleeding, bowel changes, weight loss and pain.
- Blood count, ferritin and other relevant results if available; do not delay seeking care to complete them.
- Family history of colon/rectal cancer or significant polyps: which relative and age at diagnosis.
For broader health planning, our check-up guide based on age and personal risk may help. An existing positive test should not, however, be left for next year's check-up list.
Scientific References
Sources checked: 8 September 2026. Numbers in the text correspond to the references below. Study rates are not personal risk estimates; screening and follow-up recommendations may vary with country, personal risk and procedure quality.
- MedlinePlus. Fecal Occult Blood Test (FOBT).
- American Cancer Society. Colorectal Cancer Screening Tests.
- MedlinePlus. Stool guaiac test.
- Mohan BP et al. Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive FIT. Gastrointestinal Endoscopy, 2022.
- Robertson DJ et al. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia. US Multi-Society Task Force, 2017.
- Nieuwenburg SAV et al. Effect of anticoagulants and NSAIDs on accuracy of FIT. Gut, 2019.
- Forbes N et al. Association Between Time to Colonoscopy After Positive Fecal Testing and Colorectal Cancer Outcomes: A Systematic Review. Clinical Gastroenterology and Hepatology, 2021.
- Zorzi M et al. Non-compliance with colonoscopy after a positive FIT doubles the risk of dying from colorectal cancer. Gut, 2022;71:561–567.
- National Cancer Institute. Follow-Up Colonoscopy after Positive FIT Test, 2022.
- NICE NG12. Suspected cancer: recognition and referral — colorectal cancer.
- T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. Kanser Taramaları.
- USPSTF. Colorectal Cancer: Screening. JAMA, 2021.
- NIDDK. Colonoscopy — preparation, procedure and safety.
- Jacobson BC et al. Optimizing Bowel Preparation Quality for Colonoscopy. US Multi-Society Task Force, 2025.
- ASGE/ACG. Updated Quality Indicators for Colonoscopy, 2024.
- Gupta S et al. Recommendations for Follow-Up After Colonoscopy and Polypectomy. US Multi-Society Task Force, 2020.
- NHS England. Bağırsak kanseri taraması: Kolonoskopi uygulaması. Turkish patient information, 2025.
- ASGE. Should Patients With a Positive FIT Undergo Upper Endoscopy?
- Forbes N et al. The appropriate use of fecal immunochemical testing. CMAJ, 2020.
- Monahan KJ et al. Faecal immunochemical testing in patients with signs or symptoms of suspected colorectal cancer. ACPGBI/BSG guideline. Gut, 2022.
Sources
2. Butterly, L. F., Hisey, W. M., Robinson, C. M., Kneedler, B. L., & Anderson, J. C. (2024). Association of Endoscopist Colonoscopy Quality Measures With Follow-Up Colonoscopy Outcomes After Positive Stool Tests (Multitarget Stool DNA or Fecal Immunochemical Test): Retrospective Cross-Sectional Analysis of Data From the New Hampshire Colonoscopy Registry. The American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000002817
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.